Accessibility Menu
Merit Medical Systems Stock Quote

Merit Medical Systems (NASDAQ: MMSI)

$83.35
(-1.4%)
-1.17
Price as of October 23, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$83.35
Daily Change
(-1.4%) $1.17
Day's Range
$82.43 - $84.55
Previous Close
$83.35
Open
$84.55
Beta
0.88
Volume
20,096
Average Volume
601,710
Market Cap
5B
Market Cap / Employee
$84.52M
52wk Range
$78.12 - $111.45
Revenue
-
Gross Margin
0.48%
Dividend Yield
N/A
EPS
$1.97
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Merit Medical Systems Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MMSI-12.61%+70.13%+11.21%+1,530%
S&P+16.23%+94.45%+14.22%+1,685%

Merit Medical Systems Company Info

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$381.95M13.1%
Gross Profit$184.22M14.9%
Gross Margin48.23%0.7%
Market Cap$5.52B10.6%
Market Cap / Employee$0.75M0.0%
Employees7.4K6.5%
Net Income$32.58M-8.8%
EBITDA$80.56M11.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$343.87M-46.2%
Accounts Receivable$204.16M11.9%
Inventory323.38.4%

Liabilities

Q2 2025YOY Change
Long Term Debt$810.29M-5.7%
Short Term Debt$10.26M-12.6%

Ratios

Q2 2025YOY Change
Return On Assets4.81%-0.8%
Return On Invested Capital3.67%1.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$69.56M20.2%
Operating Free Cash Flow$83.31M21.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings48.4147.6651.8447.4910.86%
Price to Book4.354.264.503.87-3.99%
Price to Sales4.454.334.673.961.89%
Price to Tangible Book Value10.4410.2114.8711.3823.37%
Price to Free Cash Flow TTM33.5331.5835.8629.465.04%
Enterprise Value to EBITDA93.9187.4083.0676.254.68%
Free Cash Flow Yield3.0%3.2%2.8%3.4%-4.80%
Return on Equity9.4%9.3%9.2%8.6%-8.97%
Total Debt$819.15M$794.67M$817.66M$820.55M-5.80%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.